Fidelity Investments’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,782,567	Closed	-$21M	–	4437
2019 Q2	$21M	Sell	1,782,567 -5,652	-0.3%	-$68.4K	﹤0.01%	1607
2019 Q1	$24.4M	Buy	1,788,219 +168,162	+10%	+$2.18M	﹤0.01%	1512
2018 Q4	$16.6M	Sell	1,620,057 -474,034	-23%	-$6.07M	﹤0.01%	1631
2018 Q3	$34.9M	Sell	2,094,091 -307,474	-13%	-$5.56M	﹤0.01%	1448
2018 Q2	$37.9M	Buy	2,401,565 +427,600	+22%	+$6.5M	﹤0.01%	1413
2018 Q1	$25.1M	Buy	1,973,965 +220,726	+13%	+$3.19M	﹤0.01%	1623
2017 Q4	$20.1M	Sell	1,753,239 -2,552,068	-59%	-$28.5M	﹤0.01%	1721
2017 Q3	$52.7M	Sell	4,305,307 -1,324,493	-24%	-$13.8M	0.01%	1281
2017 Q2	$64.5M	Sell	5,629,800 -1,847,184	-25%	-$34.2M	0.01%	1185
2017 Q1	$156M	Sell	7,476,984 -33,280	-0.4%	-$737K	0.02%	802
2016 Q4	$156M	Sell	7,510,264 -17,468	-0.2%	-$454K	0.02%	789
2016 Q3	$247M	Buy	7,527,732 +123,598	+2%	+$3.76M	0.03%	575
2016 Q2	$185M	Buy	7,404,134 +840,549	+13%	+$22.7M	0.03%	697
2016 Q1	$161M	Buy	6,563,585 +119,461	+2%	+$2.77M	0.02%	752
2015 Q4	$213M	Buy	6,444,124 +409,278	+7%	+$13.8M	0.03%	630
2015 Q3	$198M	Sell	6,034,846 -330,226	-5%	-$14M	0.03%	640
2015 Q2	$337M	Buy	6,365,072 +5,597,094	+729%	+$204M	0.04%	454
2015 Q1	$22.2M	Buy	767,978 +400,000	+109%	+$11M	﹤0.01%	1690
2014 Q4	$10.7M	Sell	367,978 -399,626	-52%	-$7.17M	﹤0.01%	1968
2014 Q3	$9.73M	Hold	767,604	–	–	﹤0.01%	2026
2014 Q2	$15.4M	Buy	+767,604	New	+$10.8M	﹤0.01%	1909

Other funds holding ALDR